FDA-ASH Sickle Cell Disease Endpoints Workshop: Welcome Address by Brett P. Giroir, MD
509 views · Published 19 October 2018 · 6:12 · Indexed 20 September 2026
Channel: American Society of Hematology · 2018 · Nonprofits & Activism
Assistant Secretary for Health Admiral Brett P. Giroir, MD, welcomes attendees at the beginning of the FDA-ASH Sickle Cell Disease Clinical Endpoints Workshop, October 17-18, in Washington, DC. The purpose of the event was to identify opportunities to bring uniformity and standards to existing sickle cell disease endpoints, identify gaps, and propose development of new endpoints as a focus for future research. Learn more about the workshop, and the ASH Sickle Cell Disease Initiative: http://www.hematology.org/Meetings/8840.aspx
More from this channel
-
1:52
Ron Reagan Accepts ASH Award - Stem Cell Research
-
3:56
ASH and the Reagans Support Stem Cell Research
-
6:35
ASH News TV: Late Breaking Abstracts & ASH SAP 5th Addition
-
2:34
ASH State-of-the-Art Symposium
-
3:42
CLL-IPI: A New and Improved Staging System for CLL?
-
4:44
About the ASH Clinical Research Training Institute
-
6:56
Joseph M. Connors, MD: Optimizing Therapy, Minimizing Toxicity in Hodgkin Lymphoma
-
1:30
2017 ASH MHM: Focus on Leukemia – Anjali Advani, MD